| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -78.1% |
| Cost of Revenue | $72.8M | -19.2% |
| R&D Expense | $80.5M | -47.3% |
| SG&A Expense | $117.2M | -6.6% |
| Operating Income | -$285.3M | +24.2% |
| Pre-tax Income | -$278.9M | +19.6% |
| Income Tax | $52K | -29.7% |
| Net Income | -$278.9M | +19.6% |
| EPS (Basic) | -$5.44 | +60.8% |
| EPS (Diluted) | -$5.44 | +60.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.7M | -19.0% |
| Short-term Investments | $162.3M | -57.8% |
| Current Assets | $372.9M | -40.6% |
| Total Assets | $803.2M | -16.4% |
| Current Liabilities | $209.3M | +39.5% |
| Long-term Debt | $324.2M | -22.8% |
| Total Liabilities | $529.2M | -17.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$240.1M | +31.9% |
| Capital Expenditures | $198.0M | +62.5% |
| Investing Cash Flow | $90.8M | -48.3% |
| Financing Cash Flow | $114.1M | -15.0% |
| Free Cash Flow | -$438.2M | +7.7% |
| $274.0M |
| -15.0% |